Literature DB >> 17622242

A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.

Samir El-Andaloussi1, Henrik J Johansson, Tina Holm, Ulo Langel.   

Abstract

Cell-penetrating peptides (CPPs) have attracted increasing attention in the past decade as a result of their high potential to convey various, otherwise impermeable, bioactive agents across cellular plasma membranes. Albeit different CPPs have proven potent in delivery of different cargoes, there is generally a correlation between high efficacy and cytotoxicity for these peptides. Hence, it is of great importance to find new, non-toxic CPPs with more widespread delivery properties. We present a novel CPP, M918, that efficiently translocates various cells in a non-toxic fashion. In line with most other CPPs, the peptide is internalized mainly via endocytosis, and in particular macropinocytosis, but independent of glycosaminoglycans on the cell surface. In addition, in a splice correction assay using antisense peptide nucleic acid (PNA) conjugated via a disulphide bridge to M918 (M918-PNA), we observed a dose-dependent increase in correct splicing, exceeding the effect of other CPPs. Our data demonstrate that M918 is a novel CPP that can be used to translocate different cargoes inside various cells efficiently.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622242     DOI: 10.1038/sj.mt.6300255

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  31 in total

Review 1.  Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.

Authors:  Maria Moccia; Mauro F A Adamo; Michele Saviano
Journal:  Artif DNA PNA XNA       Date:  2016-01-11

2.  Cell penetrating peptides: how do they do it?

Authors:  Henry D Herce; Angel E Garcia
Journal:  J Biol Phys       Date:  2008-05-15       Impact factor: 1.365

3.  Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum.

Authors:  Liutao Du; Refik Kayali; Carmen Bertoni; Francesca Fike; Hailiang Hu; Patrick L Iversen; Richard A Gatti
Journal:  Hum Mol Genet       Date:  2011-05-16       Impact factor: 6.150

4.  Delivery of BACE1 siRNA mediated by TARBP-BTP fusion protein reduces β-amyloid deposits in a transgenic mouse model of Alzheimer's disease.

Authors:  Mohamed Mohamed Haroon; Kamal Saba; Venkata Harshavardhan Boddedda; Jerald Mahesh Kumar; Anant Bahadur Patel; Vijaya Gopal
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 5.  Development of protein mimics for intracellular delivery.

Authors:  Brittany M deRonde; Gregory N Tew
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

Review 6.  RNAi therapeutic strategies for acute respiratory distress syndrome.

Authors:  Melissa L Jagrosse; David A Dean; Arshad Rahman; Bradley L Nilsson
Journal:  Transl Res       Date:  2019-07-27       Impact factor: 7.012

7.  Enhancing the Cellular Delivery of Nanoparticles using Lipo-Oligoarginine Peptides.

Authors:  Jae Sam Lee; Ching-Hsuan Tung
Journal:  Adv Funct Mater       Date:  2012-07-27       Impact factor: 18.808

8.  Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.

Authors:  Olaspers Sara Eriksson; Miriam Geörg; Hong Sjölinder; Rannar Sillard; Staffan Lindberg; Ulo Langel; Ann-Beth Jonsson
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

9.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.